The aim of this study was to evaluate the prognostic impact of quantitative estrogen receptor (ER) expression at relapse for ER-positive breast cancer with ER-positive recurrence.A total of 81 patients with ER-positive primary breast cancer and ER-positive paired recurrence were included. ER expression was evaluated as the percentage of tumor cells staining for ER under immunohistochemistry. Samples were defined as ER-high (ER>50
作者:Maria Vittoria, Dieci;Federico, Piacentini;Massimo, Dominici;Claudia, Omarini;Aicha, Goubar;Guido, Ficarra;Pierfranco, Conte;Valentina, Guarneri
来源:Anticancer research 2014 年 34卷 7期